| __timestamp | Agios Pharmaceuticals, Inc. | Pharming Group N.V. |
|---|---|---|
| Wednesday, January 1, 2014 | 19120000 | 4042025 |
| Thursday, January 1, 2015 | 35992000 | 5279557 |
| Friday, January 1, 2016 | 50714000 | 8073913 |
| Sunday, January 1, 2017 | 71124000 | 44864073 |
| Monday, January 1, 2018 | 114145000 | 53488904 |
| Tuesday, January 1, 2019 | 132034000 | 65896361 |
| Wednesday, January 1, 2020 | 149070000 | 69968267 |
| Friday, January 1, 2021 | 121445000 | 92047281 |
| Saturday, January 1, 2022 | 121673000 | 131819000 |
| Sunday, January 1, 2023 | 119903000 | 87501000 |
| Monday, January 1, 2024 | 156784000 |
Unveiling the hidden dimensions of data
In the competitive world of biotechnology, managing Selling, General, and Administrative (SG&A) expenses is crucial for financial health. Over the past decade, Agios Pharmaceuticals, Inc. and Pharming Group N.V. have shown distinct strategies in optimizing these costs. From 2014 to 2023, Agios Pharmaceuticals saw a steady increase in SG&A expenses, peaking in 2020 with a 680% rise from 2014. Meanwhile, Pharming Group N.V. demonstrated a more volatile pattern, with a significant spike in 2022, marking a 3,160% increase from 2014. Despite these fluctuations, Pharming Group's expenses remained lower than Agios's until 2022. This data highlights the contrasting approaches of these companies in managing operational costs, reflecting their strategic priorities and market challenges. As the biotech industry evolves, understanding these financial dynamics offers valuable insights into corporate efficiency and sustainability.
Selling, General, and Administrative Costs: Eli Lilly and Company vs Pharming Group N.V.
Cost Management Insights: SG&A Expenses for Amgen Inc. and Agios Pharmaceuticals, Inc.
Comparing SG&A Expenses: Viatris Inc. vs Pharming Group N.V. Trends and Insights
SG&A Efficiency Analysis: Comparing BioMarin Pharmaceutical Inc. and Agios Pharmaceuticals, Inc.
Selling, General, and Administrative Costs: Sarepta Therapeutics, Inc. vs Pharming Group N.V.
Comparing SG&A Expenses: Pharming Group N.V. vs Xenon Pharmaceuticals Inc. Trends and Insights
Pharming Group N.V. vs HUTCHMED (China) Limited: SG&A Expense Trends
Who Optimizes SG&A Costs Better? CymaBay Therapeutics, Inc. or Agios Pharmaceuticals, Inc.
Breaking Down SG&A Expenses: Vericel Corporation vs Agios Pharmaceuticals, Inc.
Breaking Down SG&A Expenses: Agios Pharmaceuticals, Inc. vs Geron Corporation
Agios Pharmaceuticals, Inc. vs Novavax, Inc.: SG&A Expense Trends
Operational Costs Compared: SG&A Analysis of Agios Pharmaceuticals, Inc. and Viridian Therapeutics, Inc.